1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics 2021 - Europe

Pathology Analysis & Statistics 2021 - Europe

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Global Markets Direct

All regions

1-30 of 97 reports

Rubella (German Measles) (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • October 2021
  • 44 pages

Rubella (German Measles) (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Rubella (German Measles) - Drugs In Development, 2021, ...

  • Germany
  • Infectious Disease
  • Drug Development
  • Industry analysis
  • Health Provider Density
  • Infectious Disease Prevalence

Post Menopausal Osteoporosis (Musculoskeletal) - Drugs In Development, 2021

  • $ 2000
  • August 2021
  • 137 pages

Post Menopausal Osteoporosis (Musculoskeletal) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Drugs In Development, ...

  • World
  • Shandong
  • Musculoskeletal Disorder
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Number Of R&D Personnel

Pompe Disease (Musculoskeletal) - Drugs In Development, 2021

  • $ 2000
  • August 2021
  • 121 pages

Pompe Disease (Musculoskeletal) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pompe Disease - Drugs In Development, 2021, provides an overview of ...

  • World
  • Belgium
  • Neurological Disorder
  • Drug Development
  • Industry analysis
  • Number Of R&D Personnel
  • Manufacturing Output

Thalassemia (Hematology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 278 pages

Thalassemia (Hematology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Drugs In Development, 2021, provides an overview of the Thalassemia ...

  • World
  • Spain
  • Blood Disease
  • Drug Development
  • Industry analysis
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

Idiopathic Thrombocytopenic Purpura (Hematology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 205 pages

Idiopathic Thrombocytopenic Purpura (Hematology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Thrombocytopenic Purpura - Drugs In Development, ...

  • World
  • South Africa
  • Blood Disease
  • Autoimmune Disease
  • Industry analysis
  • Pharmaceutical Registrations
  • Drug Approval

Influenza A Virus, H3N2 Subtype Infections (Infectious Disease) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 173 pages

Influenza A Virus, H3N2 Subtype Infections (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H3N2 Subtype Infections ...

  • World
  • Netherlands
  • Influenza
  • Drug Development
  • Industry analysis
  • Vaccination Coverage
  • Drug Approval

B-Cell Chronic Lymphocytic Leukemia (Oncology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 220 pages

B-Cell Chronic Lymphocytic Leukemia (Oncology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Chronic Lymphocytic Leukemia - Drugs In Development, ...

  • World
  • Northern Europe
  • Leukemia
  • Drug Development
  • Industry analysis
  • Cause-Specific Mortality Rate
  • Stem Cell Transplantation

Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 332 pages

Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Ebolavirus Infections (Ebola ...

  • World
  • United States
  • Infectious Disease
  • Drug Development
  • Industry analysis
  • Mortality Rate
  • Hospital Discharge

Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 262 pages

Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Epstein-Barr Virus (HHV-4) Infections - ...

  • World
  • China
  • Infectious Disease
  • Drug Development
  • Industry analysis
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 178 pages

Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H5N1 Subtype Infections ...

  • World
  • Netherlands
  • Influenza
  • Drug Development
  • Industry analysis
  • Vaccination Coverage
  • Drug Approval

Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 291 pages

Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections ...

  • World
  • United States
  • Influenza
  • Drug Development
  • Industry analysis
  • Vaccination Coverage
  • Drug Approval

Glomerulonephritis (Genitourinary Disorders) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 403 pages

Glomerulonephritis (Genitourinary Disorders) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Glomerulonephritis - Drugs In Development, 2021, provides ...

  • Spain
  • Jiangsu
  • Drug Development
  • Autoimmune Disease
  • Industry analysis
  • Pharmaceutical Registrations
  • Drug Approval

Allergic Rhinitis (Respiratory) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 218 pages

Allergic Rhinitis (Respiratory) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Drugs In Development, 2021, provides an overview ...

  • World
  • China
  • Respiratory Disease
  • Allergy Drug
  • Industry analysis
  • Pharmaceutical Registrations
  • Medicine Use

Cystic Fibrosis (Respiratory) - Drugs In Development, 2021

  • $ 2500
  • July 2021
  • 545 pages

Cystic Fibrosis (Respiratory) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Drugs In Development, 2021, provides an overview of ...

  • World
  • Europe
  • Cystic Fibrosis
  • Industry analysis

Epidermolysis Bullosa (Dermatology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 169 pages

Epidermolysis Bullosa (Dermatology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Epidermolysis Bullosa - Drugs In Development, 2021, provides an ...

  • World
  • Spain
  • Dermatological Condition
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Dropout Rate

Peanut Allergy (Immunology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 176 pages

Peanut Allergy (Immunology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Drugs In Development, 2021, provides an overview of the ...

  • World
  • United Kingdom
  • Allergy
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Dropout Rate

Myocarditis (Cardiovascular) - Drugs In Development, 2021

  • $ 2000
  • June 2021
  • 57 pages

Myocarditis (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis (Cardiovascular) - Drugs In Development, 2021, provides an ...

  • World
  • Sweden
  • Cardiovascular Disease
  • Drug Development
  • Industry analysis
  • Child Mortality
  • Hospital Discharge

Dilated Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021

  • $ 2000
  • March 2021
  • 71 pages

Dilated Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Dilated Cardiomyopathy - Drugs in Development, 2021, provides ...

  • World
  • Germany
  • Cardiovascular Disease
  • Cardiology
  • Industry analysis
  • Surgical Procedures Performed
  • Drug Approval

Smallpox (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • March 2021
  • 88 pages

Smallpox (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Smallpox - Drugs in Development, 2021, provides an overview of the Smallpox ...

  • World
  • Northern Europe
  • Infectious Disease
  • Industry analysis
  • Mortality Rate
  • Manufacturing Orders

Amyloidosis (Metabolic Disorder) - Drugs in Development, 2021

  • $ 2000
  • March 2021
  • 304 pages

Amyloidosis (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Drugs in Development, 2021, provides an overview of ...

  • World
  • United Kingdom
  • Therapy
  • Pharmaceutical
  • Industry analysis
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Drugs in Development, 2021

  • $ 3500
  • March 2021
  • 63 pages

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Drugs in Development, 2021 Summary Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide ...

  • World
  • Northern Europe
  • Therapy
  • Pharmaceutical
  • Industry analysis
  • Diabetes Prevalence
  • Food Consumption

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Drugs in Development, 2021

  • $ 3500
  • March 2021
  • 87 pages

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Drugs in Development, 2021 Summary According to the recently published report ’Lysosomal Alpha Glucosidase - Drugs ...

  • World
  • Belgium
  • Neurological Disorder
  • Therapy
  • Industry analysis
  • Number Of R&D Personnel
  • Pharmaceutical Exports

Interleukin 1 (IL1) - Drugs in Development, 2021

  • $ 3500
  • March 2021
  • 162 pages

Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close ...

  • World
  • United Kingdom
  • Pathology
  • Pharmaceutical
  • Industry analysis
  • Drug Approval
  • Pharmaceutical Registrations

Rubella (German Measles) - Pipeline Review, H2 2020

  • $ 2000
  • November 2020
  • 45 pages

Rubella (German Measles) - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Rubella - Pipeline Review, H2 2020, provides an overview of the Rubella (Infectious ...

  • Germany
  • Infectious Disease
  • Industry analysis
  • Infectious Disease Prevalence
  • Health Provider Density

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2020

  • $ 2000
  • November 2020
  • 319 pages

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Respiratory Syncytial Virus Infections - Pipeline Review, ...

  • Northern Europe
  • Infectious Disease
  • Industry analysis
  • Drug Approval
  • Child Mortality

Yellow Fever - Pipeline Review, H2 2020

  • $ 2500
  • October 2020
  • 71 pages

Yellow Fever - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Yellow Fever - Pipeline Review, H2 2020, provides an overview of the Yellow Fever (Infectious ...

  • World
  • Northern Europe
  • Infectious Disease
  • Industry analysis
  • Cause-Specific Mortality Rate
  • Hospital Discharge

Post Menopausal Osteoporosis - Pipeline Review, H2 2020

  • $ 2000
  • October 2020
  • 131 pages

Post Menopausal Osteoporosis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Pipeline Review, H2 2020, provides an ...

  • World
  • Shandong
  • Musculoskeletal Disorder
  • Industry analysis
  • Pharmaceutical Registrations
  • Number Of R&D Personnel

Epidermolysis Bullosa - Pipeline Review, H2 2020

  • $ 2000
  • October 2020
  • 170 pages

Epidermolysis Bullosa - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Epidermolysis Bullosa - Pipeline Review, H2 2020, provides an overview of the ...

  • World
  • Spain
  • Dermatological Condition
  • Industry analysis
  • Pharmaceutical Registrations
  • Mortality Rate

Cystic Fibrosis - Pipeline Review, H2 2020

  • $ 2500
  • October 2020
  • 550 pages

Cystic Fibrosis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Pipeline Review, H2 2020, provides an overview of the Cystic Fibrosis ...

  • Europe
  • World
  • Cystic Fibrosis
  • Company research
  • Company

Pompe Disease - Pipeline Review, H2 2020

  • $ 2000
  • October 2020
  • 104 pages

Pompe Disease - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pompe Disease - Pipeline Review, H2 2020, provides an overview of the Pompe Disease ...

  • World
  • Belgium
  • Neurological Disorder
  • Industry analysis
  • Number Of R&D Personnel
  • Pharmaceutical Exports

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on